Patents by Inventor Chava Perry

Chava Perry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACETYLCHOLINESTERASE (ACHE)-DERIVED PEPTIDE AS AN INDUCER OF GRANULOCYTOPOIESIS, USES AND METHODS THEREOF
    Publication number: 20110039791
    Abstract: The present invention describes the use of an AChE-R-derived peptide, also known as ARP, as an inducer of hemopoietic cell differentiation and expansion, specifically for the granulocytic population. In addition, the use of ARP as an inducer of thrombopoietin and pro-inflammatory cytokines is also presented. ARP may further be used in the pre-transplant priming of hematopoietic stem cells. Other uses and methods utilizing ARP are also described herein.
    Type: Application
    Filed: September 24, 2010
    Publication date: February 17, 2011
    Applicants: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, Medical Research Fund at the Tel Aviv Sourasky Medical Center
    Inventors: Hermona Soreq, Dan Grisaru, Varda Deutsch, Chava Perry, Marjorie Pick
  • Acetylcholinesterase (ACHE)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof
    Patent number: 7838493
    Abstract: The present invention describes the use of an AChE-R-derived peptide, also known as ARP, as an inducer of hemopoietic cell differentiation and expansion, specifically for the granulocytic population. In addition, the use of ARP as an inducer of thrombopoietin and pro-inflammatory cytokines is also presented. ARP may further be used in the pre-transplant priming of hematopoietic stem cells. Other uses and methods utilizing ARP are also described herein.
    Type: Grant
    Filed: February 10, 2005
    Date of Patent: November 23, 2010
    Assignees: Yissum Research Development Company of the Hebrew University of Jerusalem, Medical Research Fund at the Tel Aviv Sourasky Medical Center
    Inventors: Hermona Soreq, Dan Grisaru, Varda Deutsch, Chava Perry, Marjorie Pick
  • Arp as an Inducer of Granulocytopoiesis, Uses and Methods Thereof
    Publication number: 20070224181
    Abstract: The present invention describes the use of an AChE-R-derived peptide, also known as ARP, as an inducer of hemopoietic cell differentiation and expansion, specifically for the granulocytic population. In addition, the use of ARP as an inducer of thrombopoietin and pro-inflammatory cytokines is also presented. ARP may further be used in the pre-transplant priming of hematopoietic stem cells. Other uses and methods utilizing ARP are also described herein.
    Type: Application
    Filed: February 10, 2005
    Publication date: September 27, 2007
    Inventors: Hermona Soreq, Dan Grisaru, Varda Deutsch, Chava Perry, Marjorie Pick